KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Other Non-Current Liabilities: 2014-2016

Historic Other Non-Current Liabilities for Xenon Pharmaceuticals (XENE) over the last 3 years, with Dec 2016 value amounting to $70,000.

  • Xenon Pharmaceuticals' Other Non-Current Liabilities was N/A to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year change of. This contributed to the annual value of $70,000 for FY2016, which is 47.37% down from last year.
  • Per Xenon Pharmaceuticals' latest filing, its Other Non-Current Liabilities stood at $70,000 for FY2016, which was down 47.37% from $133,000 recorded in FY2015.
  • In the past 5 years, Xenon Pharmaceuticals' Other Non-Current Liabilities registered a high of $196,000 during FY2014, and its lowest value of $70,000 during FY2016.
  • Moreover, its 3-year median value for Other Non-Current Liabilities was $133,000 (2015), whereas its average is $133,000.
  • Data for Xenon Pharmaceuticals' Other Non-Current Liabilities shows a maximum YoY tumbled of 47.37% (in 2016) over the last 5 years.
  • Yearly analysis of 3 years shows Xenon Pharmaceuticals' Other Non-Current Liabilities stood at $196,000 in 2014, then plummeted by 32.14% to $133,000 in 2015, then crashed by 47.37% to $70,000 in 2016.